MMedication Read More GLP-1 drugs reshaping fitness: UAE experts stress strength training is keyJuly 25, 2026 For decades, the fitness industry revolved around one goal — helping people lose weight. Today, the growing popularity…
MMedication Read More Allergy medication sold nationwide recalled for potentially life-threatening mix-up with wrong pillsJuly 25, 2026 (Gray News) — An over-the-counter allergy medication sold nationwide is being recalled for a mix-up with another medication…
MMedication Read More Raleigh-area patient hopeful of new FDA-approved cholesterol pillJuly 25, 2026 RALEIGH, N.C. (WTVD) — For nearly two years, Steve Church has been working with doctors to keep his…
MMedication Read More Newly approved pill cuts LDL cholesterol levels by more than halfJuly 24, 2026 A new pill that dramatically lowers harmful LDL cholesterol may be a good option for people who can’t…
MMedication Read More FDA peptide votes could open the door to more unproven drugs: ‘Pandora’s box’July 24, 2026 A Food and Drug Administration advisory committee on Friday recommended allowing two more unproven peptides to be compounded,…
MMedication Read More CHMP Backs EU Approval of Trixeo for Asthma MaintenanceJuly 24, 2026 AstraZeneca’s fixed-dose triple-combination Trixeo Aerosphere (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) has been recommended for approval in the European…
MMedication Read More New GLP-1 Clinical Study Finds Calocurb Reduces Body Weight and Fat » World Business OutlookJuly 24, 2026 Calocurb, the New Zealand-based company bringing the world the first 100% natural GLP-1 activator, recently announced the publication…
MMedication Read More There’s a lack of proof to back up the peptides hype – AFRJuly 24, 2026 There’s a lack of proof to back up the peptides hype AFRUS health panel recommends easing restrictions on controversial…
MMedication Read More Health news round-up: coffee, ADHD prescribing, and GLP-1s and hair lossJuly 24, 2026 The first cohort of MPharm pharmacist prescribers received their General Pharmaceutical Council (GPhC) registration results this week, with…
MMedication Read More Lilly to file for next-gen obesity drug approval in early 2027July 24, 2026 Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in…
MMedication Read More The billion-dollar problem keeping Ozempic, Wegovy, and Zepbound from patientsJuly 24, 2026 GLP-1 medications have been shown to improve health and offer strong value for their price, yet many insurance…
MMedication Read More Can Ozempic rewire the addicted brain? : NPRJuly 24, 2026 Part 1 of the TED Radio Hour episode Rethinking addiction in the age of Ozempic GLP-1s revolutionized weight-loss and diabetes…